BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27273729)

  • 1. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
    Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
    Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
    Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4
    Guo Y; Wang Q; Li D; Onyema OO; Mei Z; Manafi A; Banerjee A; Mahgoub B; Stoler MH; Barker TH; Wilkes DS; Gelman AE; Kreisel D; Krupnick AS
    Am J Transplant; 2019 Oct; 19(10):2705-2718. PubMed ID: 31278849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.
    Warnecke G; Bushell A; Nadig SN; Wood KJ
    Transplantation; 2007 Jun; 83(11):1459-65. PubMed ID: 17565319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines affecting CD4
    Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
    Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW; Kish DD; Fairchild RL
    J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
    Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
    Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses.
    Nayak DK; Zhou F; Xu M; Huang J; Tsuji M; Hachem R; Mohanakumar T
    Am J Transplant; 2016 Aug; 16(8):2300-11. PubMed ID: 27062199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloactivation of Naïve CD4
    Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM
    Front Immunol; 2019; 10():2397. PubMed ID: 31681288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.
    Davies JK; Barbon CM; Voskertchian A; Nadler LM; Guinan EC
    Cell Transplant; 2012; 21(9):2047-61. PubMed ID: 22507909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
    Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.